Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Histo-blood group A is a risk factor for severe COVID-19.
Transfus Med. 2022 Jun;32(3):248-251. doi: 10.1111/tme.12796. Epub 2021 Jun 3.
Transfus Med. 2022.
PMID: 34085363
Free PMC article.
High-Dose Convalescent Plasma for Treatment of Severe COVID-19.
De Santis GC, Oliveira LC, Garibaldi PMM, Almado CEL, Croda J, Arcanjo GGA, Oliveira ÉAF, Tonacio AC, Langhi DM Jr, Bordin JO, Gilio RN, Palma LC, Santos EV, Haddad SK, Prado BPA Jr, Pontelli MC, Gomes R, Miranda CH, Auxiliadora Martins M, Covas DT, Arruda E, Fonseca BAL, Calado RT.
De Santis GC, et al. Among authors: gilio rn.
Emerg Infect Dis. 2022 Mar;28(3):548-555. doi: 10.3201/eid2803.212299. Epub 2022 Jan 26.
Emerg Infect Dis. 2022.
PMID: 35081022
Free PMC article.
Clinical Trial.
Item in Clipboard
Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID).
Lemos ACB, do Espírito Santo DA, Salvetti MC, Gilio RN, Agra LB, Pazin-Filho A, Miranda CH.
Lemos ACB, et al. Among authors: gilio rn.
Thromb Res. 2020 Dec;196:359-366. doi: 10.1016/j.thromres.2020.09.026. Epub 2020 Sep 21.
Thromb Res. 2020.
PMID: 32977137
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite